Compound 1573
Identifiers
- Canonical SMILES:
CCOc1cc(ccc1C1=N[C@H]([C@@H](N1C(=O)N1CCC(CC1)n1c2ccccc2[nH]c1=O)c1ccc(Cl)cc1)c1ccc(Cl)cc1)C(F)(F)F
- IUPAC name:
3-[1-[4,5-bis(4-chlorophenyl)-2-[2-ethoxy-4-(trifluoromethyl)phenyl]-4,5-dihydroimidazole-1-carbonyl]piperidin-4-yl]-1H-benzimidazol-2-one
- InChi:
InChI=1S/C37H32Cl2F3N5O3/c1-2-50-31-21-24(37(40,41)42)11-16-28(31)34-44-32(22-7-12-25(38)13-8-22)33(23-9-14-26(39)15-10-23)47(34)36(49)45-19-17-27(18-20-45)46-30-6-4-3-5-29(30)43-35(46)48/h3-16,21,27,32-33H,2,17-20H2,1H3,(H,43,48)/t32-,33-/m0/s1
- InChiKey:
GBEWNNRCXVTBHZ-LQJZCPKCSA-N
External links
![]() 168317941 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Publication | Name |
---|---|
Gregory Jay Haley, Norman Kong, Emily Aijun Liu, Klaus B. Simonsen, Binh Thanh Vu, Stephen Evan Webber, F. Hoffmann-La Roche Ag. . Cis-2,4,5-triaryl-imidazolines None. | 26 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
MDM2-Like / P53 | 6.10 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 721.18 g/mol | |||
HBA | 8 | |||
HBD | 1 | |||
HBA + HBD | 9 | |||
AlogP | 8.10 | |||
TPSA | 77.48 | |||
RB | 7 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2005003097 | 26 | MDM2 Q00987 |
|
Biochemical assay | Time-Resolved FRET | pIC50 (half maximal inhibitory concentration, -log10) | 6.10 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.7206 | RO-5045337 | DB14793 | |
0.7155 | Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone | DB04144 | |
0.6480 | Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone | DB02872 | |
0.4270 | Telcagepant | DB12228 | |
0.4007 | Metralindole | DB09306 | |
0.3926 | Gepotidacin | DB12134 | |
0.3880 | Copanlisib | DB12483 | |
0.3836 | Oxatomide | DB12877 | |
0.3816 | Tirabrutinib | DB15227 | |
0.3806 | SD146 | DB02729 | |
0.3798 | PCO-371 | DB14946 | |
0.3746 | Ganirelix | DB06785 | |
0.3720 | 2-[2-ETHANESULFONYLAMINO-3-(5-PROPOXY-1H-INDOL-3-YL)-PROPIONYLAMINO]-PENTANEDIOIC ACID 5-AMIDE 1-(4-CARBAMIMIDOYL-BENZYLAMIDE) | DB04606 | |
0.3718 | Imazaquin | DB04582 | |
0.3705 | TAK-448 | DB11975 |